Callan Capital’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,758
| Closed | -$87.6K | – | 316 |
|
|
2024
Q1 | $87.6K | Sell |
4,758
-415
| -8% | -$7.64K | 0.01% | 292 |
|
|
2023
Q4 | $82.1K | Hold |
5,173
| – | – | 0.01% | 226 |
|
|
2023
Q3 | $97.5K | Hold |
5,173
| – | – | 0.01% | 196 |
|
|
2023
Q2 | $117K | Hold |
5,173
| – | – | 0.01% | 177 |
|
|
2023
Q1 | $131K | Hold |
5,173
| – | – | 0.02% | 176 |
|
|
2022
Q4 | $78.2K | Buy |
+5,173
| New | +$78.2K | 0.01% | 182 |
|
|
2016
Q3 | – | Sell |
-593
| Closed | -$122K | – | 51 |
|
|
2016
Q2 | $122K | Buy |
+593
| New | +$122K | 0.05% | 64 |
|